| |
|
|
|
La Jolla Pharmaceutical Company  
|
|
9.9 0.19 (0.02%) |
06-17 16:00 |
|
Open: |
9.72 |
Pre close: |
9.71 |
Target:
|
16.24
|
|
High: |
10.0599 |
Low: |
9.6607 |
Resistance:
|
13.90
16.24
|
|
Volume: |
494,549 |
Market Cap: |
268M |
Support:
|
8.50
5.17
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
9.81
 |
MACD |
MACD(12,26):
|
0.94  |
|
MA(20): |
7.46 |
Signal(12,26,9): |
0.60 |
|
MA(100): |
6.89 |
Stochastic Oscillator |
%K(14,3):
|
53.23 |
|
MA(250): |
14.63 |
%D(3): |
52.59 |
|
Average Volume(K) |
3-Month: |
129745
|
52-Week |
High:
|
38.39 |
|
10-Days: |
549540 |
Low: |
5.01 |
|
RSI |
RSI(14):
|
61.16 |
Change(%): |
-67.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-7.900 |
Return on Equity (ttm) |
-249.6 |
Shares Out. (M) |
27.10 |
|
EPS Est. Current Year |
-4.990 |
Return on Assets (ttm) |
-100.9 |
Shares Float (M) |
25.50 |
|
EPS Est. Next Year |
-3.970 |
PEG Ratio |
-0.11 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-1.420 |
Qtrly Rev. Growth |
443.3 |
% Held by Institutions |
0.00 |
|
Forward EPS |
-2.611 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
37.520 |
EBITDA (p.s.) |
0.000 |
P/E |
-1.25 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.26 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-139.20 |
P/S |
526058816.00 |
|
Operating Margin |
-1233.15 |
Levered Free Cash Flow
(M) |
-79.27 |
P/CF |
-1.93 |
|
|
|
|
|
|
